Search

everythinglearnresearchcommunity

for

Search:↓

CCCA can appear as patchy hair loss in younger men, not just the usual pattern.

Hesperidin may help reduce hair loss by protecting hair follicles.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

There is no standard treatment for CCCA, and practices vary widely.

Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.

Xtressé™ gummies may help increase hair growth in women, especially in early hair loss stages.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Patients with central centrifugal cicatricial alopecia benefit from shared decision-making with their doctors.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Low-dose metformin may help hair regrowth and reduce inflammation in CCCA.

Black women with CCCA are more likely to have uterine fibroids.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

Diagnosing and treating CCCA requires understanding multiple causes and using various diagnostic tools.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

The document concludes that more local research on African skin and hair is needed despite increased scientific output from Sub-Saharan Africa.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

The letter suggests that the study's comparison group might have affected the results and calls for larger, more detailed future research.

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.